SIRT1 mediates salidroside‐elicited protective effects against MPP+‐induced apoptosis and oxidative stress in SH‐SY5Y cells: involvement in suppressing MAPK …
CY Wang, ZN Sun, MX Wang… - Cell biology …, 2018 - Wiley Online Library
Parkinson's disease (PD) is a progressive neurodegenerative disease, leading to tremor,
rigidity, bradykinesia, and gait impairment. Salidroside has been reported to exhibit …
rigidity, bradykinesia, and gait impairment. Salidroside has been reported to exhibit …
SIRT1 mediates salidroside-elicited protective effects against MPP+-induced apoptosis and oxidative stress in SH-SY5Y cells: involvement in suppressing MAPK …
CY Wang, ZN Sun, MX Wang… - Cell biology …, 2018 - pubmed.ncbi.nlm.nih.gov
Parkinson's disease (PD) is a progressive neurodegenerative disease, leading to tremor,
rigidity, bradykinesia, and gait impairment. Salidroside has been reported to exhibit …
rigidity, bradykinesia, and gait impairment. Salidroside has been reported to exhibit …
SIRT1 mediates salidroside-elicited protective effects against MPP+ -induced apoptosis and oxidative stress in SH-SY5Y cells: involvement in suppressing MAPK …
CY Wang, ZN Sun, MX Wang, C Zhang - Cell Biology International, 2017 - europepmc.org
Parkinson's disease (PD) is a progressive neurodegenerative disease, leading to tremor,
rigidity, bradykinesia, and gait impairment. Salidroside has been reported to exhibit …
rigidity, bradykinesia, and gait impairment. Salidroside has been reported to exhibit …
SIRT1 mediates salidroside-elicited protective effects against MPP+-induced apoptosis and oxidative stress in SH-SY5Y cells: involvement in suppressing MAPK …
CY Wang, ZN Sun, MX Wang… - Cell Biology …, 2018 - search.ebscohost.com
Parkinson's disease (PD) is a progressive neurodegenerative disease, leading to tremor,
rigidity, bradykinesia, and gait impairment. Salidroside has been reported to exhibit …
rigidity, bradykinesia, and gait impairment. Salidroside has been reported to exhibit …